Clinical Trial

Antineoplastic Drugs in Elderly Patients

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose is to study the population pharmacokinetics, effectiveness and safety of antineoplastic drugs (Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib, Imatinib, Lapatinib, etc) in elderly patients and recommend optimized dosage regimens.
Trial Details
NCT Number NCT05467189
Lead Sponsor Shandong University
Collaborators: Qianfoshan Hospital, The Second Hospital of Shandong University, The Affiliated Hospital of Qingdao University
Conditions Cancer
Enrollment 500 participants
Start Date 2021-01-01
Primary Completion 2028-03-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2022-07-20